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Abstract
Ability to form cellular aggregations such as tumorspheres and spheroids have been used
as a morphological marker of malignant cancer cells and in particular cancer stem cells
(CSC). However, the common definition of the types of cellular aggregation formed by can-
cer cells has not been available. We examined morphologies of 67 cell lines cultured on
three dimensional morphology enhancing NanoCulture Plates (NCP) and classified the
types of cellular aggregates that form. Among the 67 cell lines, 49 cell lines formed spheres
or spheroids, 8 cell lines formed grape-like aggregation (GLA), 8 cell lines formed other
types of aggregation, and 3 cell lines formed monolayer sheets. Seven GLA-forming cell
lines were derived from adenocarcinoma among the 8 lines. A neuroendocrine adenocarci-
noma cell line PC-3 formed asymmetric GLA with ductal structures on the NCPs and rapidly
growing asymmetric tumors that metastasized to lymph nodes in immunocompromised
mice. In contrast, another adenocarcinoma cell line DU-145 formed spheroids in vitro and
spheroid-like tumors in vivo that did not metastasize to lymph nodes until day 50 after trans-
plantation. Culture in the 3D nanoenvironment and in a defined stem cell medium enabled
the neuroendocrine adenocarcinoma cells to form slowly growing large organoids that
expressed multiple stem cell markers, neuroendocrine markers, intercellular adhesion mole-
cules, and oncogenes in vitro. In contrast, the more commonly used 2D serum-contained
environment reduced intercellular adhesion and induced mesenchymal transition and
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promoted rapid growth of the cells. In addition, the 3D stemness nanoenvironment promoted
secretion of HSP90 and EpCAM-exosomes, a marker of CSC phenotype, from the neuroen-
docrine organoids. These findings indicate that the NCP-based 3D environment enables
cells to form stem cell tumoroids with multipotency and model more accurately the in vivo
tumor status at the levels of morphology and gene expression.
Introduction
Two-dimensional (2D) monolayer culture carried out using specially prepared polystyrene
dishes has revolutionized modern biology, allowing precise and reproducible experimentation.
The modified plastic is able to bind fibronectin and vitronectin from serum, thus offering a
surface for cell adhesion [1]. However, the 2D culture conditions can enhance integrin signal-
ing and thus mask many aspects of cellular physiology [2]. In contrast, three-dimensional (3D)
cell culture can replicate some aspects of the physiological or pathological milieu, such as the
intratumoral microenvironment [3] and thus be more suitable for some aspects of cancer
research. For instance, the mesenchymal transition of non-small cell lung carcinoma (NSCLC)
cell lines was much more efficiently induced on 3D cell culture condition than under 2D con-
ditions [4]. Alteration of epithelial-mesenchymal transition (EMT) properties of lung adeno-
carcinoma cell line A549 was efficiently quantified using the NanoCulture Plate (NCP)-based
3D cell culture system [5]. The NCPs are cell/tissue culture plates with patterned nanoscale
grids that restrict cells from sprawling on the base and enables cells to migrate more readily
than in monolayer cell culture [6]. Cells migrate from one scaffold to another scaffold on the
grid on the NCPs more actively than cells cultured on the 2D plates, a property reminiscent of
tumor cell behavior. The increased migration and reduced attachment of cells to the NCPs
also enable them to form 3D cell aggregates. Other advantages of the NCP are that it does not
require gel materials [6] and cells cultured on NCPs have higher rates of proliferation compa-
rable with those cultured on 2D plates. The NCP-based cell-culture system can also be useful
for selection of malignant cancer cells that can grow under anchorage-independent conditions
as also shown in soft-agar. The NCP-based 3D cell-culture method is thus suitable for assessing
key phenotypic changes in tumor progression. Indeed, an EMT quantification system utilizing
the NCPs contributed to a discovery of a novel EMT inhibitor [5]. However, in addition to
EMT, the treatment of cancer cells is a further unsolved risk for patient death.
Regression versus progression of tumors depends on a balance between immunity [7, 8],
the tumor microenvironment [9], and the strength of carcinogenic stimuli [10–12]. Tumors
are often resistant to immunity [13], chemotherapy [14, 15] and radiation therapy [16] due
to clonal evolution which generates multiple variant genotypes and thus novel phenotypes in
cancer cells [17–20]. Gene expression of the stress resistance protein HSP family is elevated
and potentially responsible for resistance in such advanced cancer cells [21–27]. The tumor
microenvironment consists of cancer cells including cancer stem cells (CSC) [28–30], cancer-
associated fibroblasts (CAF) [31, 32], mesenchymal stem cells (MSC) [33–35], immune /
inflammatory cells [36–38], and vascular endothelial cells [39]. These types of cells within the
tumor microenvironment communicate via cell surface molecules, secretory factors and/or
extracellular vesicles and play key roles in tumor progression [40, 41]. Hypoxic microenviron-
ments have been also shown to arise in tumors in vivo, due the cells outgrowing the local
microcirculation [42–44]. Hypoxia then leads to induction of transcription factors, HIF1α and
HIF2α, shown to target multiple genes, including stem cell-related genes such as OCT4/
POU5F1, IL-6, hTERT, Notch, Notch ligand DLL4, TGFα and ABC transporter genes [42–
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44]. Therefore, we hypothesized that hypoxia within the tumor microenvironment could
enhance stem cell phenotypes. The interior of cell aggregates (tumoroids) formed by strong
intercellular adhesion can also become highly hypoxic and thus stemness may potentially be
induced in vitro in non-adherent cell culture and in vivo in tumors. By contrast, the frequently
used 2D in vitro cell culture system is directly exposed to oxygen and does not model the con-
ditions of in vivo hypoxic tumors. In the present study, we have examined altered expression
of SC markers and identify genes in the highly hypoxic enlarged tumoroids (cell aggregates)
generated in the NCP-based 3D culture system.
Stem cells were first found in hematopoietic cells and thus designated hematopoietic stem
cells (HSCs) [45]. Unequivocal proof of HSCs has given way to the prospective isolation of tis-
sue-specific stem and progenitor cells [34, 35, 46]. Tumors may often originate from the trans-
formation of normal stem cells, and cancer cells may include sub-populations of CSCs [28, 30,
45]. Paradoxically, teratoma formation in experimental animals is one of the features of
induced pluripotent stem (iPS) cells [47, 48]. Indeed, an increased in expression of normal SC
markers has been found in cancer stem cells [34, 49, 50]. Currently defined characteristics of
CSCs are cell aggregates/spheroid formation, tumor initiation, a relatively slow cell cycle or
entrance into dormancy, exhibiting chemo-resistance, SC marker expression, and pluripo-
tency [28–30, 51–53]. Dormant cancer cells within subclones can survive chemotherapy while
proliferating subclones are relatively more chemotherapy sensitive. Thus, tumors can relapse
due to cells surviving after treatment and re-established subclonal diversity [52]. Therefore, in
the present study, we examined whether 3D cell culture conditions could induce characteris-
tics of CSCs including dormancy of the evolved castration-resistant adenocarcinoma cells.
Prostate CSCs were firstly identified by Collins et al in 2005 [54]. Several biomarkers of
CSCs in prostate and other types of cancers have been shown, including CD133/PROM1 [54–
56], CD326/EpCAM [56], a chemokine receptor CXCR4 [55, 57], aldehyde dehydrogenase
(ALDH) activity [58], Integrin α2 and β1 [54], stimulus-independent PTEN/Akt/PI3K signal-
ing [59], protein fucosylation [60] and CD44 alternative splicing variants (CD44v) [61, 62].
Expression of many of these molecules is associated with a poor prognosis in patients [63–65].
Although CD44 has been used as a biomarker of CSCs, it has been shown more recently that
CD44 variants could be expressed in such cells. The CD44 transcripts expressed in most cells
are known as CD44 standard (CD44s) and do not contain sequences from an interior variable
region and does promote EMT [66]. Epithelial splicing regulatory proteins (ESRP1 and
ESRP2) have been shown to regulate epithelial cell-type-specific splicing [67], including
CD44v / CD44s switching regulated by ESRP1 in breast cancer cells [66]. The expression of
ESRP2 was shown to be suppressed by TGF-β through induction of ZEB1 and ZEB2 [68]. In
addition, growth factor-dependent and independent activations of receptor tyrosine kinases
(RTKs) have been shown to stimulate the PI3K-Akt pathway-dependent EMT [69]. We
recently showed that NCPs induce cellular aggregation (tumoroids) mediated by the intercel-
lular adhesion molecule E-cadherin in vitro, whereas TGF-β signaling oppositely repressed cel-
lular aggregation via promotion of EMT on the NCP-based 3D cell culture system [5]. Thus,
EMT promotes transformation and migration of cancer cells, whereas inhibition of EMT
increases intercellular adhesion and thus promotes cellular aggregation. Under these condi-
tions, drug-resistant CSCs can be concentrated and initiate recurrence- a phenomenon called
the “EMT-CSC paradox”. The EMT-CSC paradox is contradicted to the model that EMT
induces CSC phenotypes [14, 70]. The complicated relationship between the EMT and CSC
phenotypes has not been unequivocally resolved yet. In the present study, we have aimed to
clarify the EMT-CSC paradox.
To define the nature of cell aggregates formed on NCPs, we first examined sixty seven cell
lines cultured under these conditions and classified their varied morphologies. Such
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morphologies included: spheres (a regular three-dimensional object in which every cross-sec-
tion is a circle), spheroids (similar form to spheres, but not quite the same. Distorted sphere-
like structure), grape-like aggregation (GLA), other types of aggregation, and monolayer
sheets. We also showed that expression of stem cell marker genes and oncogenes were
increased in the cell aggregates formed by castration-resistant neuroendocrine adenocarci-
noma cells growing under the 3D conditions.
Materials and methods
Cells
PC-3, MCF7, T47-D, DLD-1, SW480, MiaPaCa-2, BT474, MDA-MB-231, COLO205, HT29,
SW620, BT-20, BxPC-3, Capan-1, Capan-2, COLO201, HCC1806, HCC1954, HCT-116,
Hep3B, Hs578T, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H2030, NCI-H23, NCI-H441,
OVCAR-3, PLC/PRF/5, RKO, SNU-16, SNU-5, WiDr, Calu-1, HeLa, SK-BR-3, ZR-75-30,
BT549, HeLa, ACHN, MDA-MB-435S, DU-145, LNCaP, RWPE1, CAL 27, FaDu, and SK-OV-3
were obtained from American Tissue Culture Collection. MKN-45, MKN-74, huH-1, U251,
HSC-3, HSC-3-M3, Colon26, and 3T3L1 were obtained from JCRB Cell Bank at National Insti-
tutes of Biomedical Innovation, Health, and Nutrition. HLE, HLF, JHH-2, JHH-5, JHH-6, JHH-7,
ASPC-1, and SUIT-2 were obtained from National Cancer Center. A549, Panc-1, HepG2, RBE,
and Li-7 were obtained from Riken Cell Bank. RT7 was provided by Dr. Nobuyuki Kamata at
Hiroshima University. Each cell line was maintained and cultured in the recommended medium
unless otherwise specified. LuM1 and NM11 were maintained as described previously [71]. Char-
acteristics of prostate adenocarcinoma cell lines were summarized in S1 Table.
NCP-based 3D cell culture and stemness induction
For 3D culture, cells were cultured in NanoCulture Plates (NCPs) (MBL Corporation, Nagoya,
Japan) as described [5]. For stem-cell conditions, cells were cultured in mTeSR1 medium
(Stem cell technologies) containing LiCl (1 mM), basic FGF (100 ng/ml), TGF-β (23.5 pM),
GABA (1 mM), insulin (4 μM), transferrin (0.137 μM), β-mercaptoethanol (0.1 mM), choles-
terol (1.12 μM), lipids, and BSA in the DMEM/F12 basal medium [72, 73]. Photomicrographs
of cell aggregates were taken by using a microscope IX71 with a DP72 camera (Olympus).
Quantification of hypoxic cell aggregations
As described [5]. Cells were seeded at a concentration of 1,000 to 10,000 cells/well in 96-well
NCPs (MBL Corporation, Nagoya, Japan). For time-lapse analysis, cells were monitored using
Array Scan High Content Screening (HCS) System (Thermo, Waltham, MA). For hypoxia analy-
sis, a hypoxia probe Lox-1 (MBL Corporation, Nagoya, Japan) was added at a final concentration
of 2 μM the day before the measurement. The fluorescence intensity of each pixel (μm2) and per
aggregations of cells was determined using a filter set for Texas Red. Fluorescent areas greater
than 100 μm2 were counted as cellular aggregations, while those less than 100 μm2 were not. A sin-
gle well-area of a 96-well plate was sectionized to 9 fields, and the area of 1 field is 2,632 μm2. For
counting cellular aggregations, fluorescent intensity and area (μm2 = pixel) of each aggregation in
the entire cell population or per field were calculated. For time-lapse analysis, 1,000 PC-3 cells
were seeded per well in a 96-well NCP in RPMI containing 5% FBS or mTeSR1 for 7 days.
Flow cytometry
Antibodies were labeled using Phycoerythrin labeling kit NH2 (Dohjindou, Japan). Cells were
cultured in 75 cm2 tissue culture flask and detached by using trypsin/EDTA. Detached cells
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were centrifuged at 1,000 rpm for 5 min. Cells were suspended in PBS(-) at a concentration of
106 cells/ml. To a 100 μl of cells in PBS, 3 μl of antibodies were added and incubated for 1 hour
at RT. Then, 1 ml of PBS(-) was added to cell-antibody complex and centrifuged at 1,000 rpm
for 5 min. The supernatant was aspirated with a pipette and Bemcot (Asahi Kasei, Japan). This
wash step was repeated. Flow cytometry was carried out using BD Accuri C6 (BD Bioscience).
An anti-human CD44 v9 mAb (clone RV3) Phycoerythrin (PE)-labeled were obtained from
Cosmo Bio. An anti-PSA antibody IgG1κ was prepared by immunizing mouse with human
PSA (Scripps laboratories. P0725) and labeled with PE.
Splicing variant analysis (conventional RT-PCR)
As described [74]. The 1 μg of total RNA was denatured at 65˚C for 5 min, and then mixed
with 5x RT buffer, 25 pmol random 9mer, 5 pmol oligo dT primer adapted with M13 primer
M4 seq, dNTPs (final 1 mM), 40 unit RNase inhibitor and 100 unit ReverTra Ace RTase
(Toyobo, Osaka) in 20 μl reaction. The cDNA was synthesized by incubating the mixture at
30˚C for 10 min, at 42˚C for 30 min, and at 99˚C for 5 min. For PCR, 2.5 μl of the cDNA was
mixed with 10x PCR buffer, 2.5 μl of 2 mM dNTPs, forward and reverse primers (final 0.2 μM
each), and 1.25 unit Blend Taq-Plus (Toyobo, Osaka) in total 25 μl. The mixture was denatured
at 94˚C and PCR was carried out by 40 cycles of 94˚C for 30 secs, 55˚C for 30 secs, and 72˚C
for 1 min, followed by a final extension at 72˚C for 5 min. The 10 μl of PCR products were
mixed with 6x loading dye and used for electrophoresis in 11 cm x 10 cm 2% agarose gel at 100
V for 1.5 hrs., and stained in 0.5 μg/ml EtBr for 30 min, washed in ddH2O for 30 min. Primers
for CD44s/v [74] and ACTB were listed in S2 Table.
Real-time qRT-PCR
As described [35]. cDNA was synthesized by using ReverTra Ace (Toyobo, Osaka, Japan).
Real-time PCR was carried out by using SYBR Green PCR master mix plus (Toyobo) or iQ
cyber (BioRad). Primers for GAPDH, ESRP1, ESRP2 [68], ECAD/CDH1,CD133/PROM1,
CD44s and CD44v9 [75] were listed in S2 Table.
Gene expression profiling
As described [23, 35]. RT2 Profiler PCR array Human Cancer Stem Cells (SABiosciences) was
used, and the data were analyzed by using RT2 profiler PCR array data analysis ver 3.5
(SABiosciences). For building block analysis, the genes were categorized into 6 categories:
stem cell and pluripotency; hippo signaling; intercellular adhesion, anti-EMT, and Notch-delta
signaling; tyrosine kinases; pro-EMT; immune and hemangiogenic. The genes expressed at the
highest level in a condition as compared to the other conditions were counted to construct
building blocks.
Whole cell lysate
As described [5, 76]. Cells were cultured until being sub-confluent, confluent or over-conflu-
ent on 2D culture plates for 2 to 5 days, or on 35-mm NCPs for 8 to 12 days. Media were
changed every 3 days. Cells were washed with PBS (-), treated with 150 to 200 μl/dish of a 1x
RIPA buffer containing 1% NP-40, 0.1% SDS, and 0.5% deoxycholate, and protease inhibitors
in PBS (-), and collected by using a cell scraper. Cells were further lysed by a 25G needle-
syringe for 10 strokes and then incubated for 30 min on ice. The lysate was centrifuged at
12,000 x g for 20 min at 4˚C and the supernatant was used as a whole cell lysate (WCL). The
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WCL was diluted 10-fold and protein concentration was measured by using micro BCA pro-
tein assay system (ThermoFisher Scientific).
Preparation of exosomes
Cells cultured were washed with Hanks’ balanced salt solution (HBSS), and then further cul-
tured in serum-free medium for 2 days. Cell culture supernatant was centrifuged at 2,000 x g
for 30 min at 4˚C to remove detached cells. The supernatant was then centrifuged at 10,000 x g
for 30 min at 4˚C to remove cell debris. The supernatant was concentrated by using an Ultra-
15 Centrifugal Filter Devices for MW. 100,000 (Amicon). The concentrate was applied to a
polymer method using Total Exosome Isolation (ThermoFisher Scientific). The exosome frac-
tions were eluted in 100 μl PBS (-). The filtrated non-exosome fraction (< 100 kD) was applied
to Ultra-15 Centrifugal Filter Devices for MW. 10,000 (Amicon) and centrifuged at 10,000 x g
for 10 min to concentrate the fraction to less than 400 μl and then a protease inhibitor cocktail
was added. For protein assay, 10x RIPA buffer containing 10% NP-40, 1% SDS, and 5% deoxy-
cholate in PBS (-) and an EDTA-free protease inhibitor cocktail (Sigma) were added to the
exosome fraction, incubated on ice for 15 min and applied to micro BCA protein assay system
(ThermoFisher Scientific).
Transmission electron microscopy (TEM)
A 400-mesh copper grid coated with formvar/carbon films was hydrophilically treated. The
exosome suspension (5 to 10 μl) was placed on Parafilm, and the grid was floated on the exo-
some liquid and left for 15 min. The sample was negatively stained with 2% uranyl acetate solu-
tion for 2 min. exosomes on the grid were visualized with 20,000 times magnification with an
H-7650 transmission electron microscope (Hitachi, Tokyo, Japan) at Central Research Labora-
tory, Okayama University Medical School.
Western blotting analysis
As described [76]. Each protein sample per 3 x 105 cells was used for analysis of exosome, per 1
x 105 cells was used for analysis of non-exosome cell culture supernatant, and per 2 x 104 cells
was used for analysis of cell lysates. For analysis of CD9 and EpCAM, protein samples were
mixed with an SDS sample buffer without any reducing agent and boiled. Otherwise, protein
samples were mixed with the SDS sample buffer with β-mercaptoethanol, boiled, separated by
SDS-PAGE in 4–20% TGX-GEL (BioRad) or 7.5% poly-acrylamide gel, and transferred to
PVDF membranes by using a semi-dry method or tank method. Blocking and antibody reac-
tions were done in a blocking buffer containing 5% skim milk (Wako) or ECL Blocking Agent
(GE Healthcare) in Tris-buffered saline containing 0.05% Tween 20 (TBS-T). The membrane
was blocked for 1 h with shaking at RT. Each membrane was washed three times with TBS-T
for 10 min with shaking at RT and then incubated overnight with shaking at 4˚C with primary
antibodies: either mouse anti-CD9 (1:1,000, MBL), mouse anti-EpCAM (1:1,000, VU1D9,
CST), rabbit anti-Vimentin (1:1,000, D21H3, CST), rabbit anti-E-cadherin (1:1,000, 24E10,
CST). Afterwards, the membranes were incubated for 1 h with shaking at RT with horseradish
peroxidase (HRP)-conjugated secondary antibodies; either anti-mouse IgG (1:10,000, CST) or
anti-rabbit IgG (1:10,000, GE Healthcare). Washes after antibody reactions were done on a
shaker within TBS-T at RT three times for 5 min and three times for 10min. Alternatively,
membranes were incubated with HRP-conjugated mouse anti-β-actin (1:5,000, Wako) anti-
bodies for 1 h with shaking at RT. Blots were visualized with ECL Plus western blotting sub-
strate (Pierce).
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Cell proliferation and viability
Cells were seeded at a concentration of 2.3x104 cells/well in a 24-well culture plate (2D) or
24-well NCP (3D). Number of cells at day 2 to 14 were counted by using Countess automated
cell counter (Invitrogen). For detachment of adherent cells from the plates and for separation
of cell aggregates, cells were treated with 0.25% Trypsin-EDTA solution. For photomicrogra-
phy, a Floid cell imaging station (Thermo Fisher Scientific) or phase contrast microscope
(Olympus CKX 53) were used. We used the following formula. Doubling Time = duration x
log(2) / log(Final Concentration) − log(Initial Concentration).
Immunohistochemistry (IHC)
For 2D IHC, cells were cultured on coverslips coated with collagen and fixed in 4% paraformal-
dehyde in PBS (-) pH 7.4 for 10 min at RT. Fixed cells were permeabilized for 10 min in PBS
containing 0.1% Triton X-100. Endogenous peroxidases were blocked for 30 min in 1.5% H2O2
for 30 min. For blocking non-specific reactions of primary antibodies, cells were incubated for
20 min at RT in serum-free protein blocking reagent (Dako, Tokyo, Japan). Hereinafter, pri-
mary antibodies were used at 4˚C for 16 hrs. The applied primary antibodies were follows: anti-
Chromogranin A antibody (ab15160, 1:400, abcam, Cambridge, UK), anti-Vimentin antibody
(ab8978, 1:1000, abcam, Cambridge, UK), anti-EpCAM antibody (ab71916, 1:200, abcam, Cam-
bridge, UK), anti-Synaptophysin antibody (ab32127, 1:1000, abcam, Cambridge, UK) and anti-
NCAM antibody (ab9018, 1:1000, abcam, Cambridge, UK). To react with the primary antibod-
ies, peroxidase-labeled polymer (Simple Stain MAX-PO (MULTI) 1, Nichirei Biosciences,
Tokyo, Japan) was allowed to react for 30 min at RT and was developed using DAB (Liquid
DAB + Substrate Chromogen System, Dako, Tokyo, Japan) for visualizing of immunohisto-
chemical reactions. Samples were then counterstained with hematoxylin. For negative control,
the same protocol was performed under omission of the primary antibody. For analysis of
immunostaining were counted in five areas chosen from the selected regions at x200 magnifica-
tion. One hundred cells were counted in each area and positive cell ratio was calculated.
For 3D IHC, cells were cultured for 11 days and then cell aggregates were fixed in 4% para-
formaldehyde in PBS (-) for 8 min. The cell aggregates were washed with PBS (-) for 5 min 3
times and embedded in paraffin at Central Research Laboratory, Okayama University Medical
School. Antigen retrieval was performed with Histo/zyme (Diagnostic BioSystems, CA) for 5
min, and sections were incubated with blocking solution (1% BSA and 10% normal goat
serum) for 1 h and then with primary antibodies; mouse anti-EpCAM (#2929, CST, 1:200),
rabbit anti-Vimentin (#5741, CST, 1:100), and rabbit anti-E-cadherin (#3195, CST, 1:100).
Alexa Fluor Plus secondary antibodies (Thermo Scientific, Waltham, MA) were used. Fluores-
cent images were taken by using Keyence microscopy system and modified by haze reduction
programs.
In vivo tumorigenicity and metastasis
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the Japanese Pharmacological Society. The protocol
was approved by the Committee on the Ethics of Animal Experiments of the Okayama Univer-
sity (Permit Number: OKU-2016219). All surgery was performed under sodium pentobarbital
anesthesia, and all efforts were made to minimize suffering. Cells were pre-cultured on 2D
plates or 3D NCP and detached with Trypsin/EDTA. Cells (1 x 106) were subcutaneously
transplanted on the backs of SCID mice. The major and minor axis of developed tumors were
measured.
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Statistical analysis
All data are expressed as the mean ± standard deviation unless otherwise indicated. Statistical
analysis was performed using ANOVA. Differences between groups were rated significant at
values of P < 0.05 or P< 0.01.
Results
Classification of cell aggregates
Many types of cells, including tumor cells, are able to form multicellular aggregates on low-
attachment plates or NanoCulture plates (NCPs) in vitro [4–6]. In the present study, we
showed that not only spheroids/spheres but also new types of cellular aggregates could be
formed on the NCPs. Among the 67 types of cell lines that we cultured on NCPs, 8 cell lines
formed grape-like aggregation (GLA) (Fig 1A), 49 cell lines formed sphere or spheroids (Fig
1B), 8 cell lines formed other types of aggregation of cells (Fig 1C), and 3 cell line formed
monolayer epithelial-like sheets (Fig 1D) (Table 1).
Among the eight cell lines that formed GLA, seven have been shown to be poorly differenti-
ated, six of the lines were derived from adenocarcinoma, and two cell lines (PC-3 and MIA
PaCa-2) possessed neuroendocrine tumor phenotypes [77, 78]. The cells with GLA phenotypes
appeared to contain less areas of intercellular adhesion and more intercellular space and
enlarged via the proliferation of cells and fusion of the aggregations with complicated grape-
like shapes compared with the other phenotypes (Fig 1A). FaDu cells formed multiple types of
aggregations including spheroids at low concentration of cells (Fig 1C), and monolayer sheets
at higher concentration, 2 to 5 days post-seeding period. RT7 and RWPE1, which were estab-
lished by immortalizing normal epithelial cells, formed epithelial sheets (Fig 1D), indicating
that these cell lines have retained non-tumorigenic epithelial phenotypes that are close to nor-
mal epithelial cells.
It was thus suggested that while most tumor cells can form spheres/spheroids in 3D cell cul-
ture conditions, GLA of cells is indicative of another distinctive phenotype of tumor cells
growing in the 3D condition.
Difference in tumorigenicity and metastatic potentials between spheroid-
forming and GLA-forming adenocarcinomas
We next examined in vivo tumorigenicity of four different types of cell lines, including normal
prostate epithelial cell line RWPE-1, cell aggregate-forming cell line LNCaP, spheroid-forming
prostate adenocarcinoma cell lines DU-145, GLA-forming neuroendocrine adenocarcinoma
cell line PC-3 (S1 Table). The medium control, RWPE-1, and LNCaP cells did not form in
vivo tumor until day 52 after the transplantation, whereas DU-145 cells formed tumors with
sphere morphology and PC-3 cells formed tumors at day 27 with asymmetric morphology
(Fig 2A, Table 2). These morphologies of PC-3 and DU-145 tumors were consistent with their
morphologies within cell aggregates formed under NCP condition in vitro (Table 1, Fig 1, later
figures). These data suggest that cell aggregates formed on NCP might have similar character-
istics to those found in tumors in vivo. The tumors formed by the prostate neuroendocrine
cancer cell line PC-3 developed rapidly as compared to that formed by the prostate cancer cell
line DU-145 (Fig 2B, Table 2). We next examined GLA-forming PC-3 cells, by pre-culturing
the cells on 3D NCP before injection into recipient mice. The 3D-pre-cultured PC-3 cells
formed tumors in vivo (Fig 2A). In addition, such cells metastasized to multiple lymph nodes,
including regional lymph nodes of the prostate and an axilla lymph node, two months after
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transplantation (Fig 2C), whereas other cell lines did not metastasize to lymph nodes in this
timeframe (Table 2).
These findings indicate that cell aggregates formed in the 3D environment in vitro share
some properties with tumor xenografts and the GLA-forming neuroendocrine adenocarcinoma
Fig 1. Representative morphologies of the various types of cell aggregates formed on NanoCulture Plates (NCP). (A)
Grape-like aggregation (GLA) of PC-3 cells formed in F12K medium with 10% FBS. (B) Spheroids of CAL 27 cells formed in
DMEM with 10% FBS. (C) Cell aggregation of FaDu cells formed in DMEM with 10% FBS. (D) Epithelial monolayer sheet of
RT7 cells formed in KGM2 medium. Scale bar, 100 μm. The morphological classification of 67 cell lines on NCP is shown in
Table 1.
https://doi.org/10.1371/journal.pone.0191109.g001
Table 1. Classification of the morphologies of cellular aggregations.
Morphology Name of cell lines Number of cell
lines
Spheroid A549, AsPC-1, BT20, BT549, BxPC-3, CAL 27, Calu-1, Capan-1, Colon-
26, Colo-205, DU-145, HCC1806, HCC1954, HeLa, HLF, Hs578T, HSC-
3, HSC-3-M3, JIMT-1, JHH-5, JHH-6, JHH-7, Li-7, LuM1, MDA-MB-
435S, MKN-74, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H23,
NM11, SK-OV-3, Panc-1, PLC/PRF/5, RBE, WiDr
36
Sphere 3T3-L1, BT474, Capan-2, DLD-1, HCT116, Hep3B, HT29, huH-1,
MCF7, NCI-H226, NCI-H441, T47-D, U251
13
Grape-like
aggregation (GLA)
HLE, MDA-MB-231, MIA PaCa-2, MKN-45, PC-3, RKO, SK-BR-3, ZR-
75-30
8
Other type of
aggregation
ACHN, FaDu (L.C.), HepG2, JHH-2, LNCaP, SUIT-2, SW480, SW620 8
Monolayer sheet RT7, RWPE1, FaDu (H.C.) 3
- Total number of cell lines tested 67
L.C., low concentration. H.C., high concentration.
https://doi.org/10.1371/journal.pone.0191109.t001
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cells have an enhanced potential to develop in vivo tumors and metastasize when injected into
mice.
Fig 2. The difference in tumorigenicity and metastatic potentials between spheroid-forming and GLA-forming adenocarcinomas. (A) In vivo
tumorigenicity of PC-3 (GLA-forming), DU-145 (spheroid-forming), LNCaP (other type of aggregates), and RWPE-1 (monolayer sheet-forming) cells. Each cell
line was pre-cultured under the 2D conditions and transplanted to SCID mice. The PC-3 cells were pre-cultured in 2D or 3D conditions. The photographs on day
27, 52, 72, and 79 after the transplantation were shown. Arrows indicate tumors. Margins of tumors were traced with dotted lines. Tumor sizes were shown in
Table 2. (B) Tumor growth of each cell line. (C) Primary tumor and lymph node metastasis of the PC-3 cells on day 52. The primary tumor was shown with
dotted line. Metastasis was seen in the regional lymph nodes of the prostate (white arrows) and an axilla lymph node (arrow).
https://doi.org/10.1371/journal.pone.0191109.g002
Table 2. Tumor morphologies and metastatic potentials of the prostate-derived cell lines.
Transplant Morphology in NCP- based 3D culture Morphology of Tumors in vivo Major axis (mm) Metastasis
d27 d52
Medium n.d. n.d. 0 0 n.d.
RWPE-1 Monolayer sheet n.d. 0 0 n.d.
LNCaP Asymmetric GLA n.d. 0 0 n.d.
DU-145 Spheroid Spheroid 6.4 17.5 n.d.
PC-3 Asymmetric GLA Asymmetric tumor 15.4 24.2 LN
n.d., not detected. LN, lymph node. GLA, grape-like aggregation.
https://doi.org/10.1371/journal.pone.0191109.t002
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Quantification of size and hypoxia level of GLAs
There is no standardized definition of cellular aggregation. In the present study, we first
defined a cellular mass larger than 100 μm2 as a cellular aggregation for the purpose of these
studies and quantified the sizes and hypoxia levels of such structures. Moreover, as the GLA
phenotype has not yet been thoroughly investigated, we tested several tissue culture condi-
tions. We cultured PC-3 cells on NCPs in serum (BSA)-containing medium and in mTeSR1,
stem-cell-inducing medium. Smaller GLA (sGLA) were seen in the serum-containing
medium, whereas larger GLA (lGLA) occurred in the stem cell medium (Fig 3A). PC-3 cells
with axonal projections were also observed under the serum-containing 2D conditions (an
arrow), indicating serum stimulation of neuroendocrine differentiation.
Next, we examined GLA formation in PC-3 cells growing for 6 days on NCPs. The PC-3
cells formed GLAs which showed collective cell migration and fusion (Fig 3B). PC-3 cells pro-
liferated in serum-containing medium on the NCP, and the number of GLAs was increased
(Fig 3B, upper photomicrographs), whereas the PC-3 cell aggregates appeared more likely to
fuse to each other (arrowheads), forming larger GLAs in the stem-cell medium (Fig 3B, lower
photomicrographs). The PC-3 cells within GLAs showed morphological heterogeneity, includ-
ing small cells and large cells when cultured in serum-containing medium, but showed rela-
tively greater homogeneity, consisting largely of small cells in the stem-cell medium.
To further characterize the GLA phenotype of PC-3, we analyzed numbers and the average
area of cellular aggregations in a high content screening system. The average number of cellu-
lar aggregations formed in the serum-containing medium was 82.2, whereas that in the
mTeSR1 was 6.8 (Fig 3C). The average area of the cellular aggregations formed in serum-con-
taining medium was 515.1 μm2, whereas that in the mTeSR1 was 2090.1 μm2 (4.1-fold higher
than that in the serum-containing medium) (Fig 3D).
Next, we examined hypoxia levels in the cellular aggregations. The average hypoxia level (=
fluorescence intensities) in the cellular aggregations formed in the serum-containing medium
was 14135.5, whereas that in the mTeSR1 was 97611.8 (6.9-fold higher than that in the serum-
containing condition) (Fig 3E and 3F). Subsequently, we examined hypoxia levels and areas of
single cellular aggregations by scatter plot analysis. Larger hypoxic cellular aggregations were
formed in the stem-cell medium as compared to the serum-containing condition (Fig 3F, 3G
and 3H). The 99.93% of cellular aggregations was sized less than 5,000 μm2 with hypoxia levels
less than 150k and 0.07% of cellular aggregations was sized > 5,000 μm2 in the serum-contain-
ing medium. In contrast, 18.52% of cellular aggregations was >5,000 μm2 and 91.48% of cellu-
lar aggregations was sized between 100 to 5,000 μm2 (Fig 3H).
Therefore, factors contained in serum appear to promote the formation of small aggrega-
tions of cells along with proliferation but appear to decrease fusion of aggregations, whereas
the stem-cell medium promoted enlargement of cellular aggregations.
Enlargement of GLA due to slow cell proliferation and inter-GLA fusion in
the 3D stemness-inducing nanoenvironment
CSCs have been shown to proliferate relatively gradually with a long cell cycle and slow metab-
olism, and often enter into a status of dormancy [52]. We hypothesized that 3D microenviron-
ment could induce cancer cells to de-differentiate into slowly cycling stem cells, in addition to
promoting the aggregation morphology and stem cell-associated gene expression profile. We
found that 3D GLAs of PC-3 cells were increased on the confluent cellular sheets even in 2D
culture condition, suggesting the strong GLA-forming ability of this adenocarcinoma cell line
(Fig 4A). Larger GLAs but with reduced frequency were formed via inter-GLA fusion in the
3D stem environment, whereas relatively smaller sized GLAs but with increased number were
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Fig 3. Quantification of size and hypoxia level of GLAs in serum-stimulated and stemness-induction conditions. (A) The grape-like aggregation (GLA)
of PC-3 cells in the serum-contained or stem-cell medium. Scale bar, 100 μm. (B) Time-lapse imaging of maturation of GLA of PC-3 cells. Fusion of small
GLAs was seen to form larger GLAs in the stem cell induction condition. Arrowheads indicate pre-fusion aggregates. Scale bar, 100 μm. (C) Numbers of
cellular aggregations per field. A cellular aggregation sized more than 100 μm2 diameters was defined as a GLA. A well of a 96-well plate was sectionized to 9
fields, and the area of 1 field is 2,632 μm2. n = 4. Biological replicates. (D) The average area of GLAs. n = 3. Biological replicates. (E) Hypoxia levels of the
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formed in the 3D serum-contained condition (Fig 4B). (Quantitative analysis of size and num-
ber of cell aggregates were shown in Fig 3).
We next measured the rate of cell proliferation and viability of the adenocarcinoma cells in
these different conditions. The PC-3 cells grew in the 2D conditions with a doubling time of 1.1
to 2.0 days even after reaching confluency, whereas the cells grew slowly in the 3D stem condi-
tion with a doubling time of 7.2 days (Fig 4C). The proliferation of PC-3 cells under the 2D envi-
ronment did not show a large difference between the conditions of serum-stimulation and stem
cell medium (doubling time of 1.9 days and 1.9 days, respectively) (Fig 4D). We next examined
the growth of PC-3 cells in the 3D condition for 2 weeks. Serum promoted cell growth even in
the 3D condition with a doubling time of 2.4 days, whereas the 3D stem cell-inducing condition
caused cells to grow very slowly with a doubling time of 7.2 days (Fig 4E, Table 3).
In the 3D culture condition, the number of cells was decreased between day 11 and day 14
(Fig 4E), suggesting that cells died in this period. Viabilities of aggregate-forming PC-3 cells
were as usual in these four different conditions (Fig 4F and 4G), while there were tendencies
that cellular viabilities were higher in the serum-contained conditions as compared to the stem
cell medium conditions (Fig 4H and 4I) and viability was decreased depending on the cell cul-
ture period in the 3D condition (Fig 4I).
These findings suggested that the 3D and stemness-inducing conditions cause the adeno-
carcinoma cells to enter into slow cycling stemness phase, whereas 2D culture condition and
serum stimulate the cancer cells to grow rapidly.
Stem-cell-inducing medium promotes intercellular adhesion whereas
serum stimulation promotes morphological diversity of the
neuroendocrine adenocarcinoma cells
Next, we examined further morphological changes of the PC-3 cells grown in 2D and 3D con-
ditions. The PC-3 cells showed evidence of morphological diversity (heterogeneity) including
spindle-shaped cells, neuronal cells with axonal projections (arrows), intercellularly adhesive
cells, and round-shaped cells in the serum-containing medium in 2D condition (Fig 5A). In
contrast, PC-3 cells appeared to possess increased numbers of intercellular adhesions in the
stem-cell medium in 2D condition. The PC-3 cells formed smaller cellular aggregations in
serum-containing 3D condition and formed larger cellular aggregations with more intercellu-
lar adhesion in the stem-cell medium in 3D condition. These results indicate that the intercel-
lular adhesion and cellular aggregation are strengthened in the stem-cell medium both in 2D
and 3D conditions, whereas the loss of intercellular adhesion and cellular differentiation are
promoted in the serum-containing medium.
Gene expression switching of Epithelial-Splicing Regulatory Proteins
(ESRPs), CD44 variant, CD133, and E-cadherin depending on cell culture
nanoenvironments.
We next examined expression of CD44v,CD44s, ESRP1, ESRP2, ECAD/CDH1, and CD133/
PROM1 in the cells with epithelial intercellular adhesion induced by the stem-cell medium
(2D stem and 3D stem) and the cells with EMT induced by serum stimulation (2D serum and
3D serum), whose relative morphologies were shown above. The PCR amplicon sized approx.
aggregations. n = 3. Biological replicates. (F) Hypoxia imaging by using a hypoxia probe. Scale bars, 200 μm. (G) Scatter plot analysis of areas and hypoxic
levels of the GLAs. GLAs in random 4 fields were analyzed. Approximate straight lines were shown. Left, n = 1338. Right, n = 27. (H) The difference in sizes of
GLAs. Gray, 100 to 500 μm2; orange, 500 to 5000 μm2. Red,> 5000 μm2.
https://doi.org/10.1371/journal.pone.0191109.g003
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Fig 4. Enlargement of GLA due to slow cell proliferation and inter-gla fusion in the 3d stemness-inducing nanoenvironment. (A) Representative
photomicrographs of PC-3 cells after reaching confluent. Cells were cultured in the 2D condition. Cellular morphologies at day 4, 5, and 7 were shown.
Arrowheads indicate GLA on the 2D monolayer cells. Scale bar, 100 μm. (B) Representative photomicrographs of PC-3 cells in the 3D culture condition.
Cellular morphologies at day 11 and 14 were shown. Scale bar, 100 μm. (C) Growth curves of PC-3 cells cultured in 2D serum-contained and 3D stem
cell medium conditions. Cells were cultured in a 96-well plate. P< 0.01 (2D serum vs 3D stem), n = 3. (D) Growth curves of PC-3 cells cultured in 2D
serum-contained and 2D stem cell medium conditions. P< 0.05 (2D stem vs 2D serum), n = 3. (E) Growth curves of PC-3 cells cultured in 3D serum-
contained and 3D stem cell medium conditions. P< 0.05 (3D stem vs 3D serum), n = 3. P< 0.01 (3D stem vs 3D serum), n = 3. (F-H) Viabilities of
PC-3 cells cultured in 2D or 3D conditions in serum-contained or stem cell media. Same data with different vertical axis values were shown between F
and H and between G and I. (F, H) P< 0.05 (2D serum vs 2D stem), n = 3. (G, I) P< 0.05 (vs day 0), n = 3. P< 0.01 (vs day 0), n = 3. 3D serum d0 vs
d7, P = 0.028. 3D serum d0 vs d11, P = 0.0052. 3D serum d0 vs d14, P = 0.0012. 3D stem d0 vs d7, P = 0.0138. 3D stem d0 vs d11, P = 0.0007. 3D stem d0
vs d14, P = 0.0004.
https://doi.org/10.1371/journal.pone.0191109.g004
Cancer stem cell organoids secrete exosomes and HSP in 3D nanoenvironment
PLOS ONE | https://doi.org/10.1371/journal.pone.0191109 February 7, 2018 14 / 34
700 bp was consistent with CD44v8-10, which was expressed in the 2D and 3D stemness condi-
tion (Fig 5B and 5C). Minor PCR amplicons sized approx. 680 bp, 900 bp, and 800 bp that
were consistent with CD44v6-10were also detected in the stemness conditions; however, nei-
ther of the amplicons consistent with CD44v2-10 (should be approx. 1100 bp) nor CD44v9
(should be approx. 600 bp) were detected. The PCR amplicon sized approx. 304 bp was consis-
tent with the CD44s, which was expressed in the 2D and 3D serum-containing conditions at
high levels, but at lower levels in the 2D and 3D stemness conditions. We next examined the
mRNA levels of the v9 region-containing CD44v using the primer pairs as shown in Fig 5B
(green) and of CD44s using the CD44s-specific primer pair as shown in Fig 5B (blue). The
CD44smRNA was expressed at high levels in the 2D and 3D serum-containing conditions, but
at relatively low levels in the stem-cell medium, further indicating that CD44swas expressed
under the EMT-promoting conditions. CD44v containing the v9 region was expressed at high
levels in the 2D and 3D stem-cell conditions (Fig 5D), whereas this transcript was at low levels
in the serum-containing condition, consistent with the agarose gel electrophoresis analysis as
shown in Fig 5C. These results indicated that CD44v8-10 is expressed in the stem-cell-induced
adhesive PC-3 cells, while CD44s is expressed at high levels in the serum-containing condi-
tions. The mRNA levels of ECAD/CDH1,ESRP1 and ESRP2 were increased in the stemness
conditions, with intercellular adhesion and 3D conditions (Fig 5D) but were at a low level in
the serum-containing 2D condition, coincidently with the expression pattern of CD44v8-10
and with the cell/cellular aggregation morphologies as shown in Fig 3A. We next examined
CD133/PROM1 expression, which has been known as a prostate CSC marker as well as tissue
stem-cell marker (54). CD133 was expressed at a high level in the 3D stem cell aggregations
and 2D stem-cell conditions as compared to those in the serum-containing conditions.
We next examined the cell-surface expression of CD44 variant containing V9 region at the
protein level. The CD44v containing the V9 region was presented on approx. 48% of PC-3
cells at passage number 2 (S1 Fig); however, it was lost by culturing the cells in serum-contain-
ing medium (22.0% at P3, 11.2% at P7, and 0% at P11) (Fig 5E). Some factors contained in
serum might promote differentiation of the cells and reduced stemness.
These results indicate that CD44v8-10,ESRP1, ESRP2, ECAD, and CD133 are expressed at
relatively high levels in the stem-cell condition in PC-3 cells with intercellular adhesion,
whereas CD44s is expressed at high levels in the serum-induced differentiated cells.
Gene expression profiling of CSC markers in the 2D and 3D culture
nanoenvironments
To connect the altered aggregation phenotypes with gene expression signatures, we carried out
gene expression profiling of CSC markers under 2D and 3D conditions. We tested four condi-
tions- 3D culture in the stem-cell medium on the NCPs (3D stem), 3D culture in serum-con-
taining medium on the NCPs (3D serum), 2D culture in mTeSR1 medium (2D stem), and 2D
culture in serum-containing medium (2D serum). The gene expression signatures were ana-
lyzed in clustergram (Fig 6A). The number of genes expressed at high level in the 3D, stem-cell
condition was 29 in total, including DLL1, MUC1, and EPCAM. The number of genes
expressed at high level in the 3D, serum-containing condition was 30 genes in all, including
DACH1, SCA1/ATXN1, ALDH1A1, and NANOG. Twelve genes were expressed at high level in
Table 3. Doubling time of the neuroendocrine PC-3 cells in the 4 different conditions.
Condition 2D serum 2D stem 3D serum 3D stem
Doubling time 1.9 days 1.9 days 2.4 days 7.2 days
https://doi.org/10.1371/journal.pone.0191109.t003
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the 2D, stem-cell conditions, including CXCL8. The Number of genes expressed at high level
in the 2D, serum-containing condition was 19, including ZEB1,AXL, and ID1.
Next, in order to look down upon the different gene expression signatures, we categorized
the genes into 6 groups, including: a group of transcripts promoting stem cell properties and
pluripotency; a group of hippo signaling; a group of transcripts promoting intercellular adhe-
sion, anti-EMT and Notch signaling; a group of tyrosine kinase genes; a pro-EMT group; and
a group of immunity and hemangiogenic genes. According to these categories, we performed
building block analysis (Fig 6B). Stemness- and pluripotency-related genes were expressed in
3D conditions at high levels. Nine stem cell marker genes were expressed in the 3D stem-cell
condition (SOX2, MYC, MYCN, GATA3, LIN28A, LIN28B, JAK2, CD44, PROM1/CD133), 11
stem cell marker genes were expressed in the 3D serum-containing condition (OCT4/POU5F1,
NANOG, KLF4, ALDH1A1,WNT1, STAT3, JAK2, CD44, PROM1/CD133, BMP7, SCA1/
ATXN1), whereas only one stem cell marker gene was expressed in the 2D conditions (FZD7,
BMI1) (purple blocks), indicating that stemness-related genes were upregulated in the 3D
NCP condition and could be involved in the formation of tumor cell aggregations.
Nine intercellular adhesion genes including anti-EMT genes and Notch/Delta/Jag signal-
related genes (EPCAM, ALCAM, CD24,NOTCH1, NOTCH2, DLL1, DLL4, JAG1) were
expressed in the 3D stem-cell condition, whereas less than four adhesion genes (DACH1,
TGFBR1, SNAI1, ZEB1, ZEB2, TWIST1) were expressed in the other condition tested, indicat-
ing that adhesion-related, anti-EMT, and Notch signaling genes were upregulated in the 3D
stem-cell condition and contributed to the formation of large aggregations.
Three Hippo signaling genes were expressed in the 3D stem-cell condition (YAP1, LATS1,
and SAV1), 2 Hippo signaling genes were expressed in the 3D serum-containing condition
(LATS and MERTK), whereas 1 Hippo signaling genes were expressed in the 2D conditions
(WWC1, TAZ), indicating that Hippo signaling could promote cell aggregation.
Three immune and hemangiogenic genes (CD34, ID1, CD31/PECAM) and 3 pro-EMT
genes were expressed in the 2D serum-containing condition, whereas less than 2 immune and
hemangiogenic genes (CXCL8, ALCAM), or pro EMT genes were expressed in the 3D condi-
tions, indicating that serum could promote cell differentiation and heterogeneity in the 2D cul-
ture condition. These results indicate that stem-cell gene expression signature accurately
represents the molecular background of the cell morphology including the size of cellular
aggregations and diversity/heterogeneity.
The NCP-based 3D environment enables neuroendocrine adenocarcinoma
cells to express stem cell marker genes and oncogenes
We next examined fold changes of gene expression in the four conditions of PC-3 cells by scat-
ter plot analysis (Fig 6C), bar graphs (Fig 7A–7C) and ranking (Tables 4 and 5). Gene
Fig 5. Gene expression switching of Epithelial-Splicing Regulatory Proteins (ESRPs), CD44 variant, and stem cell markers depending on cell
culture nanoEnvironments. (A) Representative morphologies of PC-3 cells cultured in the 4 different conditions. Cells were cultured in 10% serum-
containing F12K medium or mTeSR1 stem-cell medium on 2D plates or 3D NCPs. Arrows indicate projections of cells. Scale bars, 100 μm. (B)
Schematic structures of CD44 gene, CD44 variant 8–10 (CD44v8-10) and CD44 standard (CD44s). Blue and gray rectangles represent standard exons
(exon 1 to 10) and variant exons (V1 to V10), respectively. The red primer pair is for all variants and the CD44s. The green primer pair is for CD44v
containing exon V9. The blue primer pair is for CD44s only. (C) Agarose gel electrophoresis analysis of RT-PCR amplicons of CD44v and CD44s. An
arrow indicates CD44v8-10amplicon. An arrowhead indicates CD44s amplicon. M1k, a 1 kbp DNA ladder marker. M100, a 100 bp DNA ladder marker.
ACTB, β-actin mRNA as an internal control. (D) qRT-PCR analysis of stem-cell-related and epithelial-splicing regulatory genes. The mRNA expression
levels of CD44s,CD44v,ECAD/CDH1, ESRP1, ESRP2, and CD133were examined. Relative mRNA expression levels versus those of GAPDH are shown.
n = 3. (E) Flow cytometry analysis of CD44v9. PC-3 cells were cultured in serum-containing medium and passage number 1, 7, and 13 were examined
by flow cytometry. An anti-prostate-specific antigen (PSA) antibody was used as a negative control. Serum promoted differentiation of the cells and
reduced stemness.
https://doi.org/10.1371/journal.pone.0191109.g005
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expression of DLL (65.8-fold), EPCAM (21.3-fold), and MUC1 (18.8-fold) were induced in the
3D stem-cell condition as compared to the 2D serum-containing condition (Figs 6C and 7A,
Table 4). The gene expression of DLL, EPCAM, and MUC1were also at higher levels in the 2D
stem-cell and 3D serum-containing conditions as compared to the 2D serum-containing con-
ditions (Fig 7C). Expression of hemangiogenic genes CXCL8 (1629.3-fold) and ID1 (5.6-fold)
and EMT-related genes ZEB1 (8.0-fold) and KLF17 (7.6-fold), and RTK gene AXL (5.2-fold)
were at high levels in the 2D serum-containing condition as compared to the 3D stem-cell con-
dition (Figs 6C and 7A, Table 5). Expression of stem cell marker genes including SCA1/
Fig 6. Gene expression profiling of CSC markers in the 2D and 3D culture nanoenvironments. PC-3 cells were cultured in four different conditions
designated: 2D, serum; 2D, stem; 3D, serum; 3D, stem conditions. (A) Clustergram and dendrogram analysis of stem-cell-related genes. (B) Building block
analysis of stem-cell-related genes. (C) Scatter plot analysis. Genes were plotted according to the mRNA expression levels in the 3D stem-cell condition
(ordinate) and the 2D serum-containing condition (abscissa). #These gene’s average threshold cycle is relatively high (> 30) in any sample, and is reasonably low
in the other sample (< 30).
https://doi.org/10.1371/journal.pone.0191109.g006
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ATXN1 (13.8-fold), NANOG (10.8-fold), ALDH1A1 (10.1-fold), OCT4/POU5F1 (6.5-fold),
KLF4 (4.2-fold) and of CSC marker genes including EPCAM (5.9-fold) and MUC1 (5.3-fold)
increased in the 3D serum-containing condition as compared to the 2D serum-containing
condition, indicating that the 3D aggregation of cells on NCPs induces stemness. These results
indicate that pluripotent stemness genes and CSC genes involve cellular aggregation on NCPs.
Eight genes in the top 12 genes upregulated in the 3D stem-cell conditions have been
reported to be oncogenes, oncogenic, or oncoproteins (Table 4), encoding the epithelial cell
adhesion molecule EpCAM/CD326, mucin 1 (MUC1), stem cell antigen 1 also known as
ataxin 1 (SCA1/ATXN1), the ERBB2/HER2/NEU RTK, LIN28B a regulator of miRNA,
N-MYC, a collagen receptor tyrosine kinase DDR1, and epidermal growth factor (EGF). These
results indicate that the 3D culture condition on the NCPs let the GLA of PC-3 cells express
multiple oncogenes and stem-cell marker genes.
Secretion of EpCAM-exosomes, CD9-exosomes, and HSP90 by
neuroendocrine stem cell aggregates in the 3d culture nanoenvironment
It has been recently shown that various types of cells secrete exosomes which is one kind of
extracellular vesicles of approx. 100 nm diameter and carry various types of nucleic acid, lipid,
and proteins [41, 121–124], including tetraspanin family, EpCAM, and HSP90. EpCAM (also
known as ESA or CD326) has been shown to be oncogenic and found in CSCs as well as cancer
exosomes [56, 80, 81]. In the present study, the mRNA level of EpCAM was increased in the
3D stem cell medium environment (Table 4, Figs 6 and 7). HSP90 is a molecular chaperone
whose expression is elevated in cellular stress and cancer cells, and consists of HSP90α, an
inducible type, and HSP90β, a constitutively expressed housekeeping type [125–127] while
extracellular HSP90α [128–130] and exosomal HSP90 [122, 131–133] has been recently found.
Therefore, we examined whether aggregates of neuroendocrine PC-3 cells secrete EpCAM-
exosomes, HSP90-exosomes and/or extracellular non-exosomal HSP90 in 3D serum-stimu-
lated and stemness environments. Extracellular vesicles of approx. 100 nm diameter sur-
rounded by putative lipid bilayers were found under TEM in the exosome fraction prepared
from the culture supernatant of PC-3 cells (Fig 8A). We next examined protein storage and
exosome secretion by PC-3 cells in 2D or 3D conditions. The protein concentration per mil-
lion cells was 528.8 μg in the 2D serum-contained condition, 602.5 μg in the 2D stem cell
medium condition, 656.8 μg in the 3D serum-contained condition, and 959.9 μg (1.8-fold) in
the 3D stem cell medium condition (Fig 8B). Exosome secretion per million cells was 3.4 μg in
the 2D serum-contained condition, 6.1 μg (1.8-fold) in the 3D serum-contained condition,
6.8 μg (2.0-fold) in the 2D stem cell medium condition, and 9.5 μg (2.8-fold) in the 3D stem
cell medium condition (Fig 8C). These findings suggest that approximately 1% of cellular pro-
teins were secreted within exosomes in 48 hours, and 3D stem cell aggregates may store more
proteins in / between the cells and secrete approximately 3-fold exosomes than 2D differenti-
ated cells.
We next examined levels of EpCAM, CD9 (tetraspanin 4), and HSP90α in cells, exosomes,
and non-exosomal secretory fractions. Cellular and exosomal EpCAM levels were increased in
the 3D and stem cell medium conditions as compared to those in the 2D differentiated condi-
tion (Fig 8D), indicating that EpCAM was induced in the 3D stem cell aggregates and secreted
with exosomes. Cellular and exosome CD9 levels were significantly high in the 3D stem cell
medium environment as compared to those in 2D or serum-contained conditions (Fig 8D),
indicating that biosynthesis and secretion of exosomes increased in the 3D stem cell aggre-
gates. Non-exosomal CD9 was also found in the culture supernatant of 3D stem cell aggre-
gates, indicating that lipid bilayer of exosomes might be broken and released CD9. Non-
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exosomal HSP90α was detected abundantly in the supernatant of 3D stem cell aggregates as
compared to that of the 3D serum-stimulated cells (Fig 8D).
These findings suggest that biogenesis and secretion of CD9-exosomes, EpCAM-exosomes,
and non-exosomal HSP90α are promoted in the 3D stem cell aggregates of the neuroendo-
crine adenocarcinoma cells while these exosome-related proteins have different kinetics.
Multipotency of CSC-like neuroendocrine adenocarcinoma cells
differentiating to mesenchymal, ductal, and hemangiogenic phenotypes
PC-3 cells were originally isolated from transformed prostate adenocarcinoma and have been
shown to express a neuroendocrine cancer phenotype [134–137]. We next examined the CSC
exosome marker CD326/EpCAM, EMT indicators (E-cadherin and Vimentin), neuroendo-
crine markers (Chromogranin A and Synaptophysin) and an angiogenesis marker (CD34)
expressed in the neuroendocrine adenocarcinoma cells cultured in the 2D and 3D
Fig 7. Gene expression of stem cell markers in the 3D GLAs and differentiation markers in the 2D cells. (A) Fold expression
changes in the large GLA-forming 3D stem-cell condition vs 2D serum-containing condition. (B) Fold expression changes in the
small-GLA-forming 3D serum-containing condition vs 2D serum-containing condition. (C) Fold expression changes in the 2D
stem-cell condition vs 2D serum-containing condition. Orange bars, gene expression changed more than 8-fold. Blue bars, gene
expression changed more than 2-fold and less than 8-fold. #These gene’s average threshold cycle is relatively high (> 30) in any
sample, and is reasonably low in the other sample (< 30).
https://doi.org/10.1371/journal.pone.0191109.g007
Table 4. A gene list upregulated in cell aggregation (3D stem / 2D serum).
Gene
symbol
Fold
change
Function Reported as
oncogene?
Ref
DLL1 65.8# Delta-like ligand of Notch. Adhesion. Controversial [79]
CD326/
EpCAM
/ESA
21.3 EpICD forms complex with FHL2/β-catenin/TCF to activate myc and cyclin genes. Form complex with
tetraspanins, claudin 7, CD9, and CD44, and found in exosome.
Oncogenic [56, 80,
81]
MUC1 18.8 Encodes mucin-1 Oncoglycoprotein. Extracellular MUC1-N and membrane-bound MUC1-C have
distinctive roles. MUC1-C forms complexes with EGFR and RTKs via Galectin 3 and activate AKT-mTOR
pathway. MUC1-C dimerized and was transported to nuclei and associate with STAT1/3, NF-kB RelA,
ERα, or TCF/catenin, or to the mitochondrial outer membrane where it blocks apoptosis. Found in CSCs
and exosomes. Immunosuppressive.
Oncoprotein [82–85]
DLL4 8.2# Delta-like ligand of Notch. Adhesion. A target of HIF2α. Tumor cell DLL4 binds to Notch1 on the surface
of endothelial cells and contribute to extravasation and metastasis.(A)
Controversial [79]
ATXN1
/SCA1
4.7 Expresses in tumor initiating cells (TICs) or CSCs. expressed in TIC or
CSC
[23, 86,
87]
ERBB2/
HER2
/NEU
4.5 A member EGFR family. Form heterodimers with other members of EGFR/ERBB. The EGF ligand family
is composed of EGFs and neuregulins (NRGs). RTK. Found in exosome.
Oncogene [88, 89]
LIN28B 4.5 Stemness. Repress let-7 tumor suppressor miRNAs. Oncogenic [90–92]
MYCN 4.4 Found in neuroblastoma. Stemness. Pluripotency. Oncogene [93–96]
DDR1 3.6 Collagen receptor. RTK. Oncogenic [97, 98]
SAV1 3.4 Hippo signal. Tumor suppressor [99–
101]
DACH1 3.1# Anti-EMT, adhesion. Tumor suppressor [102–
105]
EGF 3.1 A ligand of EGFR family. Ligand of
oncoprotein
[88, 89]
Genes expressed at high levels in the 3D stem aggregation condition as compared to the 2D serum differentiation condition were listed.
#These gene’s average threshold cycle is relatively high (> 30) in any sample, and is reasonably low in the other sample (< 30).
https://doi.org/10.1371/journal.pone.0191109.t004
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environments. E-cadherin expression was found to be at high levels in the 3D cell aggregates
as compared to those in 2D culture condition (Fig 8E). In contrast, vimentin expression was at
high levels in the 2D conditions as compared to the 3D conditions. These finding indicates
that 2D and 3D culture environments are determinants of protein expression levels of E-cad-
herin and Vimentin. (See later figure regarding subcellular localization of E-cadherin and
Vimentin in cell aggregates.)
We next examined expression of EpCAM, neuroendocrine markers, EMT markers, and
CD34 in the 2D culture conditions, by performing immunocytochemistry. Vimentin-positive
cell rate was 100% in both serum-containing and stem cell-induced conditions (Fig 8F,
Table 6, S2 Fig). CD326/EpCAM positive cell rate was 64.5% in the presence of serum and
76.8% in stem cell induction medium. We next examined two markers of neuroendocrine can-
cer. Synaptophysin (SYP) positive cell rate was 3.0% in the presence of serum and that in stem
cell induction medium was 6.0%. Chromogranin A (CHGA) positive cell rate was 12.1% in the
presence of serum whereas that in stem cell induction medium was elevated to 42.7%. These
findings indicate that induction of stemness increases a neuroendocrine phenotype of the PC-
3 cells. CD34 positive cell rate was 6.4% in the presence of serum whereas that in stemness
induction medium was declined to 0.6%, indicating that this neuroendocrine adenocarcinoma
cell line has a potential to differentiate into hemangiogenic and endothelial cells. This cell line
appeared to be CD56/NCAM-negative (S2 Fig). These findings suggest that this adenocarci-
noma cell line has multipotency to differentiate into mesenchymal, neuroendocrine, and
hemangiogenic phenotypes from CSC-like characteristics.
Positivity rates were calculated from the results of immunocytochemistry shown in Fig 8E
and S2 Fig.
It is still unknown whether cavities or ducts are formed inside stem cell aggregates of the
neuroendocrine PC-3 cells. We therefore next examined morphology inside the aggregates
and localization of EpCAM, E-cadherin, and Vimentin. Cell aggregates formed in the stem-
ness-induced 3D environment were larger than those formed in the serum-contained 3D con-
dition (Fig 9). DAPI-negative cavities or duct-like structures were found inside the cell
aggregates (Fig 9). Moreover, acinus-like structures (arrow) and duct-like structures (arrow-
head) surrounded by monolayer cells were found in the serum-stimulated 3D condition (Fig
9).
Table 5. A gene list upregulated in the 2D serum-stimulated differentiation condition (2D serum / 3D stem).
Gene
symbol
Fold
change
Function Reported as
oncogene?
Ref
CXCL8 1629.3# Pro-angiogenic chemokine. - [106–
108]
ZEB1 8.0 Pro-EMT. Induced by catenin/TCF complex. Oncogenic [109–
112]
KLF17 7.6 pro- or anti-EMT. KLF17-fusion genes in myoepithelial tumors. Controversial [113–
115]
ID1 5.6 Neurogenesis, angiogenesis. Induced by BMP via Smad-binding elements. Pro-metastatic TF. Biomarker of
endothelial progenitors.
Oncogenic [116,
117]
AXL 5.2 A member of TAM RTK. Phosphatidylserine-sensing RTK. Apoptotic cell clearance, anti-viral, blood vessel
integrity. Biomarker of poor prognosis of cancer. pro-metastatic. chemoresistance.
Oncogenic [118]
PLAT 3.1# protease, plasminogen activator tissue type, tPA. Activating protease for metalloproteinases. - [119,
120]
Genes expressed at high levels in the 2D serum differentiation condition as compared to the 3D stem aggregation condition were listed.
#These gene’s average threshold cycle is relatively high (> 30) in any sample, and is reasonably low in the other sample (< 30).
https://doi.org/10.1371/journal.pone.0191109.t005
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EpCAM localized to intercellular adhesion sites and surface of the GLAs and ductal struc-
tures (Fig 9A and 9B), indicating that EpCAM contributes to formation of the CSC-like orga-
noids and EpCAM-exosomes are secreted and up-taken at the surface of the cells. Cavities
were found inside the cell aggregates in the 3D stem environment whereas acinus-like struc-
tures (Fig 9B, arrows) were found in the cell aggregates in the 3D serum-contained differentia-
tion condition.
Fig 8. Secretion of EpCAM-exosomes, CD9-exosomes, and HSP90 by 3D aggregates of multipotent neuroendocrine adenocarcinoma cells. (A) TEM of
exosomes secreted by PC-3 cells. Scale bar, 100 nm. (B, C) Cellular (B) and exosome (C) protein concentrations per million cells. PC-3 cells were pre-cultured the
four different conditions and further cultured in serum-free medium for 2 days to prepare exosome and non-exosome fractions. (D) Western blotting analysis of
EpCAM, CD9, and HSP90α in cellular, exosome, and non-exosome fractions. Each protein sample per 3 x 105 cells was used for analysis of exosome, per 1 x 105
cells was used for analysis of non-exosome fraction, and per 2 x 104 cells was used for analysis of cell lysates. (E) Western blotting analysis of E-cadherin and
Vimentin. Each protein sample per 2 x 104 cells was loaded. β-actin and GAPDH were analyzed as loading controls. (F) Immunocytochemistry of EpCAM,
vimentin, chromogranin A (CHGA), synaptophysin (SYP), and CD34 in the 2D culture conditions. Scale bar, 50 μm. Percentages of positive cells were shown in
Table 4. Photomicrographs taken at a 20 x magnification is shown in S1 Fig.
https://doi.org/10.1371/journal.pone.0191109.g008
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E-cadherin localized to intercellular adhesion sites in the 3D stem large GLA (Fig 9C),
showing mesh-like appearance. E-cadherin appeared to internalize into the cytoplasm and did
not showed mesh-like appearance in the serum-stimulated GLA while an acinus-like structure
(Fig 9D, arrow) was seen in the serum-stimulated differentiation condition.
Vimentin, an intermediate filament, also appeared to localize to intercellular adhesion sites
in the 3D stem GLA, indicating that Vimentin lined the intercellular adhesion molecules (Fig
9E) whereas Vimentin appeared to internalize into the cytoplasm in the serum-stimulated
GLA (Fig 9F). A ductal structure formed by flattened cells was seen in the serum-stimulated
differentiation condition (Fig 9F, arrowhead).
Thus, EpCAM, E-cadherin and vimentin appeared to contribute to tight and robust inter-
cellular adhesion in the organoids, in which hypoxic stem-cell properties were induced as
shown in a previous figure. Although mRNA and protein levels of E-cadherin and Vimentin
were altered in the 4 different conditions, subcellular localization of these proteins appeared to
strongly involve organization of cell aggregates. Neither E-cadherin nor Vimentin but EpCAM
appear to be responsible for intercellular adhesion for organization of the differentiating GLAs
with acinus and ductal structures.
Discussion
The development of tissue culture into a convenient methodology for basic experimentation
and for development of therapeutics has made a profound impact on the rate and quality of
cancer research [1]. However, for preclinical development there is always the drawback that
standard tissue culture methods may not accurately model conditions found in tumors. We
have compared properties of cells growing on standard tissue culture plastic plates and NCPs
that permit 3D growth in vitro [5]. In addition we have compared growth stimulation by either
serum containing medium or a defined growth medium concocted to favor stem cell growth.
These various conditions had marked effects on the properties of prostate cancer cells. The
most dramatic differences seemed to be between cells on standard dishes grown in serum con-
taining medium and those on NCPs (Figs 1 and 3–7). The former cells grew as monolayers
with a mixed morphology including both cells with epithelial and mesenchymal shapes while
those on NCP formed large three-dimensional structures with intercellular adhesions that
resembled the morphologies of primary tumors (Figs 2 and 5). These properties were reflected
in profoundly different gene expression profiles, with monolayer, serum exposed cells express-
ing to high level a number of genes associate with cell differentiation (ZEB1, KLF, AXL, ID1,
CXCL8) while NCP /stem cell medium cells expressing a number of oncogenes and stem cell
genes (DLL1, EpCAM, Muc1, Sca1, Her2, N-Myc) (Figs 6 and 7). The NCP/stem cell medium
cells also appeared to adopt a slower growing phenotype often associated with stem cells, play-
ing roles in resistance to therapy as well as reducing stem cell exhaustion (Fig 4). In addition,
the large GLA structures tended to develop hypoxic cores, again reminiscent of tumors grow-
ing in vivo (Fig 3). Our data therefore suggested that these conditions–growth on NanoCulture
Table 6. Positivity rates of markers of cancer-stem, neuroendocrine, mesenchymal, and endothelial cells.
Proteins 2D Serum 2D Stem Marker of Refs.
CD34 6.4% (32/500) 0.6% (3/500) Hemangiogenic [56, 138, 139]
Synaptophysin 3.0% (15/500) 6.0% (30/500) Neuroendocrine [134–137]
Chromogranin A 12.1% (90/743) 42.7% (253/600) Neuroendocrine [134–137]
CD326 /EpCAM 64.5% (443/687) 76.8% (375/488) CSC exosomes [56, 80, 81]
Vimentin 100% 100% Malignancy, EMT [34, 140, 141]
https://doi.org/10.1371/journal.pone.0191109.t006
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Plates might more effectively model the conditions found in growing prostate tumors. In addi-
tion, these cells were very efficient at secreting tumor exosomes that are thought to have
important properties in cancer progression (Fig 8). EpCAM-exosomes and HSP90 were found
to be abundantly secreted by the 3D stem cell aggregates of PC-3 cells. Tumor-derived exo-
somes were shown to transform induced pluripotent (iPS) cells into CSC-like cells, suggesting
a functional role for these vesicles (51).
Conclusion
The NCP-based 3D environment enables cells to form hypoxic stem cell aggregates and repro-
duce in vivo tumor status at levels of morphology and gene expression signature. These fea-
tures of NCPs may be useful for advanced tumor and stem cell biology and preclinical testing
of novel therapeutics.
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